Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Fürstenau, Moritz (VerfasserIn) , Bahlo, J. (VerfasserIn) , Fink, A. M. (VerfasserIn) , Lange, E. (VerfasserIn) , Dreger, Peter (VerfasserIn) , Dreyling, M. (VerfasserIn) , Hess, G. (VerfasserIn) , Ritgen, M. (VerfasserIn) , Kneba, M. (VerfasserIn) , Döhner, H. (VerfasserIn) , Stilgenbauer, S. (VerfasserIn) , Wendtner, C. M. (VerfasserIn) , Goede, V. (VerfasserIn) , Fischer, K. (VerfasserIn) , Böttcher, S. (VerfasserIn) , Hallek, M. (VerfasserIn) , Eichhorst, B. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: [2020]
In: Leukemia
Year: 2019, Jahrgang: 34, Heft: 3, Pages: 924-928
ISSN:1476-5551
DOI:10.1038/s41375-019-0597-3
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/s41375-019-0597-3
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/s41375-019-0597-3
Volltext
Verfasserangaben:M. Fürstenau, J. Bahlo, A.M. Fink, E. Lange, P. Dreger, M. Dreyling, G. Hess, M. Ritgen, M. Kneba, H. Döhner, S. Stilgenbauer, C.M. Wendtner, V. Goede, K. Fischer, S. Böttcher, M. Hallek, B. Eichhorst

MARC

LEADER 00000caa a2200000 c 4500
001 1694667804
003 DE-627
005 20230427070516.0
007 cr uuu---uuuuu
008 200416r20202019xx |||||o 00| ||eng c
024 7 |a 10.1038/s41375-019-0597-3  |2 doi 
035 |a (DE-627)1694667804 
035 |a (DE-599)KXP1694667804 
035 |a (OCoLC)1341314808 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Fürstenau, Moritz  |d 1986-  |e VerfasserIn  |0 (DE-588)1098210042  |0 (DE-627)857493566  |0 (DE-576)469027215  |4 aut 
245 1 0 |a Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia  |c M. Fürstenau, J. Bahlo, A.M. Fink, E. Lange, P. Dreger, M. Dreyling, G. Hess, M. Ritgen, M. Kneba, H. Döhner, S. Stilgenbauer, C.M. Wendtner, V. Goede, K. Fischer, S. Böttcher, M. Hallek, B. Eichhorst 
264 1 |c [2020] 
300 |b Diagramme 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published online: 14 October 2019 
500 |a Gesehen am 16.04.2020 
534 |c 2019 
700 1 |a Bahlo, J.  |e VerfasserIn  |4 aut 
700 1 |a Fink, A. M.  |e VerfasserIn  |4 aut 
700 1 |a Lange, E.  |e VerfasserIn  |4 aut 
700 1 |a Dreger, Peter  |e VerfasserIn  |0 (DE-588)1028891881  |0 (DE-627)732699894  |0 (DE-576)376320966  |4 aut 
700 1 |a Dreyling, M.  |e VerfasserIn  |4 aut 
700 1 |a Hess, G.  |e VerfasserIn  |4 aut 
700 1 |a Ritgen, M.  |e VerfasserIn  |4 aut 
700 1 |a Kneba, M.  |e VerfasserIn  |4 aut 
700 1 |a Döhner, H.  |e VerfasserIn  |4 aut 
700 1 |a Stilgenbauer, S.  |e VerfasserIn  |4 aut 
700 1 |a Wendtner, C. M.  |e VerfasserIn  |4 aut 
700 1 |a Goede, V.  |e VerfasserIn  |4 aut 
700 1 |a Fischer, K.  |e VerfasserIn  |4 aut 
700 1 |a Böttcher, S.  |e VerfasserIn  |4 aut 
700 1 |a Hallek, M.  |e VerfasserIn  |4 aut 
700 1 |a Eichhorst, B.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Leukemia  |d London : Springer Nature, 1997  |g 34(2020), 3, Seite 924-928  |h Online-Ressource  |w (DE-627)32046699X  |w (DE-600)2008023-2  |w (DE-576)094139733  |x 1476-5551  |7 nnas  |a Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia 
773 1 8 |g volume:34  |g year:2020  |g number:3  |g pages:924-928  |g extent:5  |a Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia 
856 4 0 |u https://doi.org/10.1038/s41375-019-0597-3  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/s41375-019-0597-3  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200416 
993 |a Article 
994 |a 2020 
998 |g 1028891881  |a Dreger, Peter  |m 1028891881:Dreger, Peter  |d 910000  |d 910100  |e 910000PD1028891881  |e 910100PD1028891881  |k 0/910000/  |k 1/910000/910100/  |p 5 
999 |a KXP-PPN1694667804  |e 3624028626 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1694667804","origin":[{"dateIssuedDisp":"[2020]","dateIssuedKey":"2020"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1694667804"],"doi":["10.1038/s41375-019-0597-3"]},"physDesc":[{"noteIll":"Diagramme","extent":"5 S."}],"note":["Published online: 14 October 2019","Gesehen am 16.04.2020"],"relHost":[{"title":[{"title_sort":"Leukemia","subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title":"Leukemia"}],"language":["eng"],"part":{"volume":"34","year":"2020","text":"34(2020), 3, Seite 924-928","pages":"924-928","extent":"5","issue":"3"},"pubHistory":["Nachgewiesen 11.1997 -"],"disp":"Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemiaLeukemia","physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2008023-2"],"issn":["1476-5551"],"eki":["32046699X"]},"note":["Gesehen am 15.03.04"],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","dateIssuedDisp":"1997-","dateIssuedKey":"1997"}],"recId":"32046699X"}],"name":{"displayForm":["M. Fürstenau, J. Bahlo, A.M. Fink, E. Lange, P. Dreger, M. Dreyling, G. Hess, M. Ritgen, M. Kneba, H. Döhner, S. Stilgenbauer, C.M. Wendtner, V. Goede, K. Fischer, S. Böttcher, M. Hallek, B. Eichhorst"]},"person":[{"display":"Fürstenau, Moritz","given":"Moritz","role":"aut","family":"Fürstenau"},{"family":"Bahlo","given":"J.","role":"aut","display":"Bahlo, J."},{"display":"Fink, A. M.","role":"aut","given":"A. M.","family":"Fink"},{"family":"Lange","given":"E.","role":"aut","display":"Lange, E."},{"display":"Dreger, Peter","role":"aut","given":"Peter","family":"Dreger"},{"role":"aut","given":"M.","display":"Dreyling, M.","family":"Dreyling"},{"family":"Hess","display":"Hess, G.","given":"G.","role":"aut"},{"family":"Ritgen","given":"M.","role":"aut","display":"Ritgen, M."},{"family":"Kneba","display":"Kneba, M.","given":"M.","role":"aut"},{"display":"Döhner, H.","given":"H.","role":"aut","family":"Döhner"},{"given":"S.","role":"aut","display":"Stilgenbauer, S.","family":"Stilgenbauer"},{"family":"Wendtner","role":"aut","given":"C. M.","display":"Wendtner, C. M."},{"display":"Goede, V.","given":"V.","role":"aut","family":"Goede"},{"role":"aut","given":"K.","display":"Fischer, K.","family":"Fischer"},{"display":"Böttcher, S.","role":"aut","given":"S.","family":"Böttcher"},{"family":"Hallek","display":"Hallek, M.","role":"aut","given":"M."},{"role":"aut","given":"B.","display":"Eichhorst, B.","family":"Eichhorst"}],"title":[{"title_sort":"Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia","title":"Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia"}],"language":["eng"]} 
SRT |a FUERSTENAURESIDUALAB2020